| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 01/09/2023 | LISATA THERAPEUTICS, INC. | CLBS | Grant | Common Stock | 20k | $0.00 | $0 | | 01/09/2023 |
| 06/22/2022 | Aquestive Therapeutics, Inc. | AQST | Grant | Stock Option (Right to Purchase) | 25k | $0.71 | $17.8k | | 06/22/2022 |
| 01/10/2022 | LISATA THERAPEUTICS, INC. | CLBS | Grant | Common Stock | 65.4k | $0.00 | $0 | | 01/10/2022 |
| 06/15/2021 | Aquestive Therapeutics, Inc. | AQST | Grant | Stock Option (Right to Purchase) | 20k | $4.04 | $80.8k | | 06/15/2021 |
| 01/11/2021 | LISATA THERAPEUTICS, INC. | CLBS | Grant | Common Stock | 37.7k | $0.00 | $0 | | 01/11/2021 |
| 06/16/2020 | Aquestive Therapeutics, Inc. | AQST | Grant | Stock Option (Right to Purchase) | 14k | $5.30 | $74.2k | | 06/16/2020 |
| 01/13/2020 | LISATA THERAPEUTICS, INC. | CLBS | Grant | Restricted Stock Units | 18.3k | $3.28 | $60k | | 01/13/2020 |
| 12/04/2019 | CAMBREX CORP | CBM | Exercise | Stock Option (right to buy) | 2.8k | $40.06 | $110.8k | | 12/04/2019 |
| 12/04/2019 | CAMBREX CORP | CBM | Exercise | Stock Option (right to buy) | 2k | $53.70 | $106.3k | | 12/04/2019 |
| 12/04/2019 | CAMBREX CORP | CBM | Exercise | Stock Option (right to buy) | 360 | $44.23 | $15.9k | | 12/04/2019 |
| 12/04/2019 | CAMBREX CORP | CBM | Sale | Common Stock | 9k | $60.00 | $540.9k | | 12/04/2019 |
| 06/13/2019 | Aquestive Therapeutics, Inc. | AQST | Grant | Stock Option (Right to Purchase) | 13.4k | $4.38 | $58.5k | | 06/13/2019 |
| 04/24/2019 | CAMBREX CORP | CBM | Grant | Stock Option (right to buy) | 2.8k | $40.06 | $110.8k | | 04/24/2019 |
| 04/24/2019 | CAMBREX CORP | CBM | Grant | Common Stock | 2.2k | $0.00 | $0 | | 04/24/2019 |
| 01/14/2019 | LISATA THERAPEUTICS, INC. | CLBS | Grant | Restricted Stock Units | 12.1k | $4.95 | $60k | | 01/14/2019 |
| 01/08/2019 | LISATA THERAPEUTICS, INC. | CLBS | Grant | Common Stock | 8.7k | $0.00 | $0 | | 01/08/2019 |
| 07/24/2018 | Aquestive Therapeutics, Inc. | AQST | Grant | Stock Option (Right to Purchase) | 26.7k | $15.00 | $400.5k | | 07/24/2018 |
| 04/26/2018 | CAMBREX CORP | CBM | Grant | Common Stock | 1.4k | $0.00 | $0 | | 04/26/2018 |
| 04/26/2018 | CAMBREX CORP | CBM | Grant | Stock Option (right to buy) | 2k | $53.70 | $106.3k | | 04/26/2018 |
| 01/08/2018 | LISATA THERAPEUTICS, INC. | CLBS | Grant | Restricted Stock Units | 8.7k | $0.00 | $0 | | 01/08/2018 |
| 10/31/2017 | CAMBREX CORP | CBM | Grant | Stock Option (right to buy) | 360 | $44.23 | $15.9k | | 10/31/2017 |
| 10/31/2017 | CAMBREX CORP | CBM | Grant | Common Stock | 265 | $0.00 | $0 | | 10/31/2017 |
| 01/09/2017 | LISATA THERAPEUTICS, INC. | CLBS | Grant | Common Stock | 1.6k | $0.00 | $0 | | 01/09/2017 |
| 01/09/2017 | LISATA THERAPEUTICS, INC. | CLBS | Grant | Options to Purchase Common Stock | 2.8k | $3.54 | $9.7k | | 01/09/2017 |